Clinical Medicine Insights: Oncology (Apr 2016)

Weekly Paclitaxel Versus Three-Weekly Paclitaxel in Recurrent Platinum-Resistant Epithelial Ovarian and Peritoneal Cancers: A Phase III Study

  • Mohammed A. Osman,
  • Mohammad S. Elkady,
  • Khalid E. Nasr

Journal volume & issue
Vol. 2016, no. 10
pp. 35 – 41

Abstract

Read online

No abstracts available.